FATE
Fate Therapeutics Inc
Price:  
3.59 
USD
Volume:  
2,557,766.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FATE Probability of Bankruptcy

The Probability of Bankruptcy of Fate Therapeutics Inc (FATE) is 46.75% . This number represents the probability that FATE will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating FATE's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

FATE - ESG ratings

ESG ratings are directly linked to the cost of capital and FATE's ability to raise funding, both of which can significantly affect the probability of Fate Therapeutics Inc going bankrupt.

ESG Score 67.83
Environment Score 70.95
Social Score 86.79
Governance Score 45.73
Returns
Historical Returns (5 day) -4.52%
Historical Returns (MTD) -2.45%
Historical Returns (YTD) -4.01%
Historical Returns (13 week) -48.71%
Historical Returns (26 week) 33.96%
Historical Returns (52 week) -38.00%
Efficiency
Asset Turnover 0.01
Receiveable Turnover 0.90
Gross Margin
Operating Margin -2,652.88%
Pretax Margin -2,493.71%
Net Margin -2,493.71%
Return on Asset (ROA) -34.48
Return on Equity (ROE) -46.49
Return on Investments (ROI) -46.49
Price Metrics
Market Cap (M) 408.65
Enterprise Value (M)
52 Week High 8.83
52 Week Low 1.63
Beta 3.64
Average Volume (10 day) 0.90
Average Volume (3 month) 0.98
Price / Earnings (P/E)
Price / Sales (P/S) 59.99
Earnings
EPS -1.92
Revenue CAGR (5 year) 68.05%
Risk
Current Ratio 8.69
Quick Ratio 8.47